We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Top Buys

Rank Stock Value
1
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$74.4M
2
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$42.5M
3
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$24.2M
4
SMH icon
VanEck Semiconductor ETF
SMH
+$17.4M
5
IWD icon
iShares Russell 1000 Value ETF
IWD
+$12.9M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$105M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29.3M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$12.8M
4
MSFT icon
Microsoft
MSFT
+$12.8M
5
AAPL icon
Apple
AAPL
+$11.9M

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RETL icon
4176
Direxion Daily Retail Bull 3X ETF
RETL
$28.9M
– –
-36,555
Closed -$434K
REX icon
4177
REX American Resources
REX
$1.43B
– –
-9,444
Closed -$127K
RGCO icon
4178
RGC Resources
RGCO
$228M
– –
-1,581
Closed -$42K
RGNX icon
4179
Regenxbio
RGNX
$722M
– –
-73
Closed -$4K
RGLS
4180
DELISTED
Regulus Therapeutics
RGLS
$0 ﹤0.01%
20
-95
-83% -$1.09K
RH icon
4181
RH
RH
$3.56B
– –
-4,494
Closed -$463K
RIGL icon
4182
Rigel Pharmaceuticals
RIGL
$733M
$0 ﹤0.01%
7
-7
-50% -$158
RILY icon
4183
BRC Group Holdings
RILY
$292M
– –
-907
Closed -$15K
RITM icon
4184
Rithm Capital
RITM
$5.55B
$0 ﹤0.01%
21
-8,187
-100% -$133K
RJF icon
4185
Raymond James Financial
RJF
$34.4B
– –
-6,203
Closed -$332K
RMAX icon
4186
RE/MAX Holdings
RMAX
$230M
– –
-2,738
Closed -$106K
RM icon
4187
Regional Management Corp
RM
$305M
– –
-816
Closed -$20K
RMCF icon
4188
Rocky Mountain Chocolate Factory
RMCF
$7.93M
– –
-2,240
Closed -$20K
RMD icon
4189
ResMed
RMD
$32.4B
– –
-2,809
Closed -$292K
ROG icon
4190
Rogers Corp
ROG
$2.39B
– –
-99
Closed -$16K
RSP icon
4191
Invesco S&P 500 Equal Weight ETF
RSP
$98.8B
– –
-8,455
Closed -$883K
RTC
4192
DELISTED
Baijiayun Group
RTC
$0 ﹤0.01%
+6
New +$70
RVPH
4193
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
– –
0
– –
RVSB icon
4194
Riverview Bancorp
RVSB
$110M
– –
-13,123
Closed -$96K
RVT icon
4195
Royce Value Trust
RVT
$2.27B
– –
-540
Closed -$7K
RWR icon
4196
State Street SPDR Dow Jones REIT ETF
RWR
$1.96B
– –
-30,440
Closed -$3.01M
RYAM icon
4197
Rayonier Advanced Materials
RYAM
$618M
– –
-100
Closed -$1K
RYZ
4198
Ryerson Holding Corp
RYZ
$1.4B
– –
-1,144
Closed -$10K
RYTM icon
4199
Rhythm Pharmaceuticals
RYTM
$7.72B
– –
-1,095
Closed -$30K
SA
4200
Seabridge Gold
SA
$3.12B
$0 ﹤0.01%
15
-5,102
-100% -$60.5K
166 167
168
169 170

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.